CRA Manager

About the role

MSD is looking for a CRA Manager in Alimos, Greece, under the oversight of the Clinical Research Department (CRD). The role ensures strong monitoring in clinical trials, manages a team of 6-14 CRAs and drives study and site performance with strict adherence to local regulations, company SOPs and ICH GCP. It is also a line-management role focused on developing talent through training, support and mentoring.

Key responsibilities

• Manage a team of 6-14 CRAs, including work allocation, staff development, performance appraisals and handling low or non-performance situations
• Contribute to capacity planning by reporting current manpower and forecasting CRA capacity and needs
• Ensure consistency of processes and protocol implementation across the country with CRAs, PLMS and other functions
• Resolve site and CRA operational issues with sites and the study CRM, attend investigator meetings when requested, and escalate issues to CRM and the Clinical Research Director
• Interface with GCTO partners on clinical trial execution and liaise with local HR and finance functions
• Provide training, support and mentoring to CRAs and ensure compliance with corporate policies, procedures and quality standards

Required profile

• Bachelor's degree in science; advanced degree in a relevant scientific or healthcare field preferred
• 8-10 years of professional experience, including at least 5 years in clinical research
• Fluent in both Greek and English
• Proven leadership, people management and team management experience preferred

Required skills

• Strong working knowledge of ICH/GCP regulations and Good Documentation Practices
• Digital proficiency with clinical systems, monitoring tools, dashboards, analytics and approved AI-enabled tools
• Time management, project management and operational coordination skills

The employer offers an attractive compensation package, outstanding benefits and a hybrid work arrangement. Candidates must hold a valid driving licence; relocation and visa sponsorship are not mentioned.